A new treatment for AMD: references



1. The World Health Organization. The World Health Report 2002-Reducing Risks, Promoting Healthy Life, pp 47-96. From the Internet @ www.who.int/whr/2002, accessed March 18, 2008.

2. National Institute for Health and Clinical Excellence (NICE). Incorporating health economics in guidelines and assessing resource impact. The Guidelines Manual, London, NICE, 2007, Chap 8. Available on the Internet @www.nice.org.uk, accessed 3-15-08.

3. Bureau of Labor and Statistics. Data on disability and unemployment. 1991/92, 1993/94, 1994/95, and 1997. From the Survey of Income and Program Participation. From the Internet @ www.bls.census.gov, accessed April 4, 2008.

4. Political calculations. Average wages in the US. http://politicalcalculations.blogspot.com, accessed 4-6-08.

5. Macular Degeneration Partnership. Available at: www.AMD.org. Accessed August 14, 2009.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.